Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: A retrospective analysis

Carli D. Needle, Elizabeth J. Klein, Jessica Gjonaj, Ambika Nohria, Maria Karim, Lynn Liu, Jinal Shah, Rebecca A. Betensky, Michael Garshick, Kristen Lo Sicco, Theodora K. Karagounis

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)659-662
Number of pages4
JournalJournal of the American Academy of Dermatology
Issue number3
StatePublished - Mar 2024


  • JAK-STAT inhibitors
  • cardiovascular adverse events
  • drug safety
  • infection
  • medication adverse effects
  • tofacitinib

ASJC Scopus subject areas

  • Dermatology

Cite this